205 related articles for article (PubMed ID: 28053055)
1. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
Cook MB; Coburn SB; Lam JR; Taylor PR; Schneider JL; Corley DA
Gut; 2018 Mar; 67(3):418-529. PubMed ID: 28053055
[TBL] [Abstract][Full Text] [Related]
2. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
4. Mortality in Barrett's oesophagus: results from a population based study.
Anderson LA; Murray LJ; Murphy SJ; Fitzpatrick DA; Johnston BT; Watson RG; McCarron P; Gavin AT
Gut; 2003 Aug; 52(8):1081-4. PubMed ID: 12865262
[TBL] [Abstract][Full Text] [Related]
5. Risk of mortality and cancer incidence in Barrett's esophagus.
Cook MB; Wild CP; Everett SM; Hardie LJ; Bani-Hani KE; Martin IG; Forman D
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2090-6. PubMed ID: 17890521
[TBL] [Abstract][Full Text] [Related]
6. Mortality rates in patients with Barrett's oesophagus.
Moayyedi P; Burch N; Akhtar-Danesh N; Enaganti SK; Harrison R; Talley NJ; Jankowski J
Aliment Pharmacol Ther; 2008 Feb; 27(4):316-20. PubMed ID: 18062791
[TBL] [Abstract][Full Text] [Related]
7. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
[TBL] [Abstract][Full Text] [Related]
8. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
9. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
10. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
[TBL] [Abstract][Full Text] [Related]
11. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS; Johnston DA
Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
Anderson LA; Watson RG; Murphy SJ; Johnston BT; Comber H; Mc Guigan J; Reynolds JV; Murray LJ
World J Gastroenterol; 2007 Mar; 13(10):1585-94. PubMed ID: 17461453
[TBL] [Abstract][Full Text] [Related]
13. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.
Schneider JL; Corley DA
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):29-39. PubMed ID: 25743454
[TBL] [Abstract][Full Text] [Related]
14. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P
Gut; 2009 Feb; 58(2):182-8. PubMed ID: 18978173
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE).
Ferraris R; Bonelli L; Conio M; Fracchia M; Lapertosa G; Aste H
Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):881-5. PubMed ID: 9355787
[TBL] [Abstract][Full Text] [Related]
16. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
[TBL] [Abstract][Full Text] [Related]
17. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus.
Schouten LJ; Steevens J; Huysentruyt CJ; Coffeng CE; Keulemans YC; van Leeuwen FE; Driessen AL; van den Brandt PA
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):754-61. PubMed ID: 21570484
[TBL] [Abstract][Full Text] [Related]
18. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
19. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
Whiteman DC; Kendall BJ
Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
Januszewicz W; Kaminski MF; Wieszczy P; Wronska E; Bielasik A; Wojciechowska U; Didkowska J; Orlowska J; Regula J
Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 27377059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
